{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:07:47Z","timestamp":1790762867316,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T00:00:00Z","timestamp":1432944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.yrtph.2015.04.018","type":"journal-article","created":{"date-parts":[[2015,4,27]],"date-time":"2015-04-27T17:33:30Z","timestamp":1430156010000},"page":"538-551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Modernizing problem formulation for risk assessment necessitates articulation of mode of action"],"prefix":"10.1016","volume":"72","author":[{"given":"Christopher J.","family":"Borgert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Wise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2015.04.018_b0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/toxsci\/53.2.159","article-title":"Lessons learned in applying the U.S. EPA proposed cancer guidelines to specific compounds","volume":"53","author":"Andersen","year":"2000","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2015.04.018_b0010","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.2174\/092986708785747535","article-title":"Expression and function of cytochrome p450-dependent enzymes in human skin cells","volume":"15","author":"Baron","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.yrtph.2015.04.018_b0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1742-7843.2009.00505.x","article-title":"Mode of action considerations in the quantitative assessment of tumour responses in the liver","volume":"106","author":"Boobis","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0020","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/10408440600977677","article-title":"IPCS framework for analyzing the relevance of a cancer mode of action for humans","volume":"36","author":"Boobis","year":"2006","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0025","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/10408390903098673","article-title":"Application of key events analysis to chemical carcinogens and noncarcinogens","volume":"49","author":"Boobis","year":"2009","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.yrtph.2015.04.018_b0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.yrtph.2011.07.007","article-title":"Hypothesis-driven weight of evidence framework for evaluating data within the US EPA\u2019s Endocrine Disruptor Screening Program","volume":"61","author":"Borgert","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/rtph.1998.1273","article-title":"A comprehensive approach for integration of toxicity and cancer risk assessments","volume":"29","author":"Butterworth","year":"1999","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0304-3835(95)03794-W","article-title":"A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments","volume":"93","author":"Butterworth","year":"1995","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yrtph.2015.04.018_b0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0378-4274(95)03543-5","article-title":"The role of regenerative cell proliferation in chloroform-induced cancer","volume":"82\u201383","author":"Butterworth","year":"1995","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2015.04.018_b0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/toxsci\/58.2.243","article-title":"Effect of trihalomethanes on cell proliferation and DNA methylation in female B6C3F1 mouse liver","volume":"58","author":"Coffin","year":"2000","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2015.04.018_b0055","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0378-4274(95)03528-1","article-title":"Biologically based dose response model for hepatic toxicity: a mechanistically based replacement for traditional estimates of noncancer risk","volume":"82\u201383","author":"Conolly","year":"1995","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2015.04.018_b0060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1006\/taap.1999.8756","article-title":"Metabolism of chloroform by cytochrome P450 2E1 is required for induction of toxicity in the liver, kidney, and nose of male mice","volume":"160","author":"Constan","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/toxsci\/66.2.201","article-title":"Chloroform inhalation exposure conditions necessary to initiate liver toxicity in female B6C3F1 mice","volume":"66","author":"Constan","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2015.04.018_b0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/toxsci\/53.1.13","article-title":"Physiologically based pharmacokinetic modeling of the temperature-dependent dermal absorption of chloroform by humans following bath water exposures","volume":"53","author":"Corley","year":"2000","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2015.04.018_b0075","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/rtph.2000.1419","article-title":"The utility of PBPK in the safety assessment of chloroform and carbon tetrachloride","volume":"32","author":"Delic","year":"2000","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0080","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.taap.2003.09.020","article-title":"Epidermal CYP2 family cytochromes P450","volume":"195","author":"Du","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/em.20368","article-title":"Evaluating genotoxicity data to identify a mode of action and its application in estimating cancer risk at low doses: a case study involving carbon tetrachloride","volume":"49","author":"Eastmond","year":"2008","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.yrtph.2015.04.018_b0090","series-title":"Interim Procedures and Guidelines for Health Risk and Economic Impact Assessments of Suspected Carcinogens","author":"EPA","year":"1976"},{"key":"10.1016\/j.yrtph.2015.04.018_b0095","series-title":"Chloroform (CASRN 67\u201366-3) Reference Dose for Chronic Oral Exposure (RfD","author":"EPA","year":"2001"},{"key":"10.1016\/j.yrtph.2015.04.018_b0100","series-title":"Toxicological Review of Carbon Tetrachloride (CAS No. 56-23-5). In Support of Summary Information on the Integrated Risk Information System (IRIS)","author":"EPA","year":"2010"},{"key":"10.1016\/j.yrtph.2015.04.018_b0105","series-title":"Framework for Human Health Risk Assessment to Inform Decision Making","author":"EPA","year":"2014"},{"key":"10.1016\/j.yrtph.2015.04.018_b0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1214\/ss\/1177012993","article-title":"From mouse-to-man: the quantitative assessment of cancer risks","author":"Freedman","year":"1988","journal-title":"Statist. Sci."},{"key":"10.1016\/j.yrtph.2015.04.018_b0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/rtph.1996.0046","article-title":"Concordance between rats and mice in bioassays for carcinogenesis","volume":"23","author":"Freedman","year":"1996","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0120","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.yrtph.2004.11.001","article-title":"Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?","volume":"41","author":"Gaylor","year":"2005","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1124\/dmd.31.3.266","article-title":"Metabolism of chloroform in the human liver and identification of the competent P450s","volume":"31","author":"Gemma","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.yrtph.2015.04.018_b0130","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/rtph.1997.1161","article-title":"Chloroform mode of action: implications for cancer risk assessment","volume":"26","author":"Golden","year":"1997","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0135","first-page":"195","article-title":"Predicting the carcinogenicity of chemicals in humans from rodent bioassay data","volume":"94","author":"Goodman","year":"1991","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.yrtph.2015.04.018_b0140","first-page":"501","article-title":"The relationship between carcinogenic potency and maximum tolerated dose is similar for mutagens and nonmutagens","volume":"369","author":"Goodman","year":"1991","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.yrtph.2015.04.018_b0145","series-title":"Introduction to toxicology. Chapter 1. A Textbook of Modern Toxicology","author":"Hodgson","year":"2012"},{"key":"10.1016\/j.yrtph.2015.04.018_b0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/toxsci\/kfj001","article-title":"Mode of action in relevance of rodent liver tumors to human cancer risk","volume":"89","author":"Holsapple","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2015.04.018_b0155","series-title":"IARC monographs on the evaluation of carcinogenic risks to humans. Reevaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide, vol. 71","author":"IARC","year":"1999"},{"key":"10.1016\/j.yrtph.2015.04.018_b0160","series-title":"IARC monographs on the evaluation of carcinogenic risks to humans. Some Chemicals that Cause Tumours of the Bladder in Rodents and Some Other Substances, vol. 73","author":"IARC","year":"1999"},{"key":"10.1016\/j.yrtph.2015.04.018_b0165","series-title":"IARC monographs on the evaluation of carcinogenic risks to humans. Preamble","author":"IARC","year":"2006"},{"key":"10.1016\/j.yrtph.2015.04.018_b0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00210-003-0819-z","article-title":"Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms","volume":"369","author":"Ingelman-Sundberg","year":"2004","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0175","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1080\/10408390903110692","article-title":"The key events dose\u2013response framework: a cross-disciplinary mode-of-action based approach to examining dose\u2013response and thresholds","volume":"49","author":"Julien","year":"2009","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.yrtph.2015.04.018_b0180","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1472-6882-12-178","article-title":"CCl4-induced hepatotoxicity: protective effect of rutin on p53, CYP2E1 and the antioxidative status in rat","volume":"12","author":"Khan","year":"2012","journal-title":"BMC Complement Altern. Med."},{"key":"10.1016\/j.yrtph.2015.04.018_b0185","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1081\/GNC-200051856","article-title":"Physiologically-based pharmacokinetic and toxicokinetic models in cancer risk assessment","volume":"23","author":"Krishnan","year":"2005","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"key":"10.1016\/j.yrtph.2015.04.018_b0190","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/15287390252807957","article-title":"Cancer risk associated with household exposure to chloroform","volume":"65","author":"L\u00e9vesque","year":"2002","journal-title":"J. Toxicol. Environ. Health A"},{"key":"10.1016\/j.yrtph.2015.04.018_b0195","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1539-6924.2007.00987.x","article-title":"Bayesian estimation of pharmacokinetic and pharmacodynamic parameters in a mode-of-action-based cancer risk assessment for chloroform","volume":"27","author":"Liao","year":"2007","journal-title":"Risk Anal."},{"key":"10.1016\/j.yrtph.2015.04.018_b0200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/toxsci\/kfq021","article-title":"Development of a quantitative model incorporating key events in a hepatotoxic mode of action to predict tumor incidence","volume":"115","author":"Luke","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2015.04.018_b0205","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/10590500701569398","article-title":"Postulated carbon tetrachloride mode of action: a review","volume":"25","author":"Manibusan","year":"2007","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"key":"10.1016\/j.yrtph.2015.04.018_b0210","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/10937400290070080","article-title":"Chloroform: exposure estimation, hazard characterization, and exposure\u2013response analysis","volume":"5","author":"Meek","year":"2002","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"10.1016\/j.yrtph.2015.04.018_b0215","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/713608373","article-title":"A framework for human relevance analysis of information on carcinogenic modes of action","volume":"33","author":"Meek","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jat.2949","article-title":"New developments in the evolution and application of the WHO\/IPCS framework on mode of action\/species concordance analysis","volume":"34","author":"Meek","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0225","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jat.2984","article-title":"Mode of action human relevance (species concordance) framework: evolution of the Bradford Hill considerations and comparative analysis of weight of evidence","volume":"34","author":"Meek","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/taap.1997.8302","article-title":"Regenerative hyperplasia is not required for liver tumor induction in female B6C3F1 mice exposed to trihalomethanes","volume":"148","author":"Melnick","year":"1998","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0235","unstructured":"NAS (National Academy of Sciences), R.R.C.C.O.I.R.A.A.U.B.T.U., Studies, N.R.C.B.O.E., Earth, N.R.C.D.O., and Studies, L., 2009. Science and Decisions: Advancing Risk Assessment. National Academies Press, Washington, DC."},{"key":"10.1016\/j.yrtph.2015.04.018_b0240","series-title":"Committee to Review the IRIS Process, Board on Environmental Studies and Toxicology, Division on Earth and Life Studies","author":"NAS (National Academy of Sciences)","year":"2014"},{"key":"10.1016\/j.yrtph.2015.04.018_b0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000257261","article-title":"Expression and induction of cytochrome p450 isoenzymes in human skin equivalents","volume":"23","author":"Neis","year":"2010","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0250","unstructured":"NTP (National Toxicology Program, U.S. Department of Health and Human Services), 2015. Report on Carcinogens, Listing Criteria: <http:\/\/ntp.niehs.nih.gov\/pubhealth\/roc\/criteria\/index.html> (accessed 02.03. 15)."},{"key":"10.1016\/j.yrtph.2015.04.018_b0255","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0041-008X(90)90148-N","article-title":"Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling","volume":"105","author":"Reitz","year":"1990","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"8","key":"10.1016\/j.yrtph.2015.04.018_b0260","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3109\/10408444.2010.499504","article-title":"Hypothesis-based weight of evidence: a tool for evaluating and communicating uncertainties and inconsistencies in the large body of evidence in proposing a carcinogenic mode of action\u2014naphthalene as an example","volume":"40","author":"Rhomberg","year":"2010","journal-title":"Crit. Rev. Toxicol."},{"issue":"7","key":"10.1016\/j.yrtph.2015.04.018_b0265","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3109\/10408444.2011.560140","article-title":"Is exposure to formaldehyde in air causally associated with leukemia? \u2013 a hypothesis-based weight of evidence analysis","volume":"41","author":"Rhomberg","year":"2011","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0270","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/10408444.2013.832727","article-title":"A survey of frameworks for best practices in weight-of-evidence analyses","volume":"43","author":"Rhomberg","year":"2013","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0275","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.yrtph.2012.03.004","article-title":"Assessment of diurnal systemic dose of agrochemicals in regulatory toxicity testing \u2013 an integrated approach without additional animal use","volume":"63","author":"Saghir","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0280","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/rtph.2001.1493","article-title":"IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis","volume":"34","author":"Sonich-Mullin","year":"2001","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2015.04.018_b0285","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/toxsci\/kfg152","article-title":"Biologically motivated computational modeling of chloroform cytolethality and regenerative cellular proliferation","volume":"75","author":"Tan","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2015.04.018_b0290","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1080\/15287390600631367","article-title":"Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform","volume":"69","author":"Tan","year":"2006","journal-title":"J. Toxicol. Environ. Health A"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230015000951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230015000951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T16:44:24Z","timestamp":1582562664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230015000951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0273230015000951"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2015.04.018","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modernizing problem formulation for risk assessment necessitates articulation of mode of action","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2015.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}